subscribeSubscribe
Sandoz`s Biologic Ziextenzo (pegfilgrastim-bmez) Receives Approval in the U.S.

Sandoz`s Biologic Ziextenzo (pegfilgrastim-bmez) Receives Approval in the U.S.
FDA
28 Feb 2024
Share Share
Coherus Announces U.S. Launch of UDENYCA ONBODY

Coherus Announces U.S. Launch of UDENYCA ONBODY
GLOBENEWSWIRE
21 Feb 2024
Share Share
Mylan`s Biologic Fulphila (pegfilgrastim) Receives Approval in the U.S.

Mylan`s Biologic Fulphila (pegfilgrastim) Receives Approval in the U.S.
FDA
13 Oct 2023
Share Share
Sandoz`s Biologic Ziextenzo (pegfilgrastim) Receives Approval in the U.S.

Sandoz`s Biologic Ziextenzo (pegfilgrastim) Receives Approval in the U.S.
FDA
09 Oct 2023
Share Share
BLA Resubmitted to FDA for On-Body Injector Presentation of Pegfilgrastim-cbqv

BLA Resubmitted to FDA for On-Body Injector Presentation of Pegfilgrastim-cbqv
ONCLIVE
06 Oct 2023
Share Share
Aurobindo`s subsidiary to withdraw mkt authorization for EU 2 biosimilar

Aurobindo`s subsidiary to withdraw mkt authorization for EU 2 biosimilar
INDIANPHARMAPOST
25 Jun 2023
Share Share
CMS grants Fresenius Kabi permanent, product-specific Q-Code for Stimufend®

CMS grants Fresenius Kabi permanent, product-specific Q-Code for Stimufend®
BUSINESSWIRE
16 May 2023
Share Share
FDA Approves UDENYCA Autoinjector

FDA Approves UDENYCA Autoinjector
GLOBENEWSWIRE
06 Mar 2023
Share Share
Stimufend® (pegfilgrastim-fpgk) Now Available in the United States

Stimufend® (pegfilgrastim-fpgk) Now Available in the United States
BUSINESSWIRE
16 Feb 2023
Share Share
Coherus` Biologic Udenyca (Pegfilgrastim) Receives Approval in the U.S.

Coherus` Biologic Udenyca (Pegfilgrastim) Receives Approval in the U.S.
FDA
28 Nov 2022
Share Share